Squalamine: A polyvalent drug of the future?

Current Cancer Drug Targets

Volumn 5, Issue 4, 2005, Pages 267-272

  Brunel, Jean Michel ^a   Salmi, Chanaz ^a   Loncle, Celine ^a   Vidal, Nicolas ^a   Letourneux, Yves ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Age related macular degeneration (AMD); Aminosterol; Appetite suppression; Cancer; Squalamine; Weight reduction

Indexed keywords

CARBOPLATIN; CYTOTOXIC AGENT; PACLITAXEL; SQUALAMINE;

ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BODY WEIGHT; BRAIN CANCER; DRUG ACTIVITY; DRUG INDICATION; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; LUNG CANCER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OVARY CANCER; RETINA MACULA AGE RELATED DEGENERATION; SHARK; SHORT SURVEY;

ANIMALS; CHOLESTANOLS; DRUG THERAPY; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 21344471697     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009054064642     Document Type: Short Survey

References (45)

1. Bax, R.; Bywater, R.; Cornaglia, G.; Goossens, H.; Hunter, P.; Isham, V.; Jarlier, V.; Jones, R.; Phillips, I.; Sahm, D.; Senn, S.; Struelens, M.; Taylor, D.; White, A. Surveillance of antimicrobial resistance-what, how and whither? Clin. Microbiol. Infect. 2001, 7, 316-325.
2. Boman, H. G. Antibacterial peptides: key components needed in immunity. Cell 1991, 65, 205-207.
3. Zasloff, M. Antibiotic peptides as mediators of innate immunity. Curr. Opin. Immunol. 1992, 4, 3-7.
4. Zasloff, M. Antibacterial molecules from frogs, sharks and man. Phylogenet. Perspect. Immun. Insect Host Def. 1994, 31-41.
5. Stone, R. Deja vu guides the way to new antimicrobial steroid. Science 1993, 259, 1125.
6. Cho, J.; Kim, Y. Sharks: a potential source of antiangiogenic factors and tumor treatments. Marine Biotechnol. 2002, 4, 521-525.
7. Savage, P. B. Design, synthesis and characterization of cat ionic peptide and steroid antibiotics. Eur. J. Org. Chem. 2002, 759-768.
8. Savage, P. B. Cationic steroid antibiotics. Curr. Med. Chem. - Anti-Infective Agents 2002, 1, 293-304.
9. Savage, P. B.; Li, C.; Taotafa, U.; Ding, B.; Guan, Q. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol. Lett. 2002, 217, 1-7.
10. Brunel, J. M.; Letourneux, Y. Recent advances in the synthesis of spermine and spermidine analogs of the shark aminosterol squalamine. Eur. J. Org. Chem. 2003, 3897-3907.
11. Moore, K. S.; Wehrli, S.; Roder, H.; Rogers, M.; Forrest, J. N. Jr.; McCrimmon, D.; Zasloff, M. Squalamine: an aminosterol antibiotic from the shark. Proc. Natl. Acad. Sci. USA 1993, 90, 1354-1358.
12. Rao, M. N.; Shinnar, A. E.; Noecker, L. A.; Chao, T. L.; Feibush, B.; Snyder, B.; Sharkansky, I.; Sarkahian, A.; Zhang, X.; Jones, S. R.; Kinney, W. A.; Zasloff, M. Aminosterols from the dogfish shark Squalus acanthias. J. Nat. Prod. 2000, 63, 631-635.
13. Wehrli, S. L.; Moore, K. S.; Roder, H.; Durell, S.; Zasloff, M. Structure of the novel steroidal antibiotic squalamine determined by two-dimensional NMR spectroscopy. Steroids 1993, 58, 370-378.
14. Moriarty, R. M.; Tuladhar, S. M.; Guo, L.; Wehrli, S. Synthesis of squalamine. A steroidal antibiotic from the shark. Tetrahedron Lett. 1994, 35, 8103-8106.
15. Moriarty, R. M.; Enache, L. A.; Kinney, W. A.; Allen, C. S.; Canary, J. W.; Tuladhar, S. M.; Guo, L. Stereoselective synthesis of squalamine dessulfate. Tetrahedron Lett. 1995, 36, 5139-5142.
16. Kinney, W. A.; Zhang, X.; Williams, J. I.; Johnston, S.; Michalak, R. S.; Deshpande, M.; Dostal, L.; Rosazza, J. P. N. A short formal synthesis of squalamine from a microbial metabolite. Org. Lett. 2000, 2, 2921-2922.
17. Zhou, X. D.; Cai, F.; Zhou, W. S. A new highly stereoselective construction of the sidechain of squalamine through improved Sharpless catalytic asymmetric dihydroxylation. Tetrahedron Lett. 2001, 42, 2537-2539.
18. Zhou, X.-D.; Cai, F.; Zhou, W.-S. A stereoselective synthesis of squalamine. Tetrahedron 2002, 58, 10293-10299.
19. Russo, T. A.; Mylotte, D. Expression of the K54 and O4 specific antigen has opposite effects on the bactericidal activity of squalamine against an extraintestinal isolate of Escherichia coli. FEMS Microbiol. Lett. 1998, 162, 311-315.
20. Selinsky, B. S.; Zhou, Z.; Fojtik, K. G.; Jones, S. R.; Dollahon, N. R.; Shinnar, A. E. The aminosterol antibiotic squalamine permeabilizes large unilamellar phospholipid vesicles. Biochim. Biophys. Acta 1998, 1370, 218-234.
21. Akhter, S.; Nath, S. K.; Tse, C. M.; Williams, J.; Zasloff, M.; Donowitz, M. Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+ exchanger isoform NHE3. Am. J. Physiol. 1999, 276, C136-C144.
22. Beck, L. Jr.; D'Amore, P. A. Vascular development: cellular and molecular regulation. FASEB J. 1997, 11, 365-373.
23. Bussolino, F.; Mantovani, A.; Persico, G. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 1997, 22, 251-256.
24. Hanahan, D. Signaling vascular morphogenesis and maintenance. Science 1997, 277, 48-50.
25. Miller, J. W.; Adamis, A. P.; Shima, D. T.; D'Amore, P. A.; Moulton, R. S.; O'Reilly, M. S.; Folkman, J.; Dvorak, H. F.; Brown, L. F. et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol. 1994, 145, 574-584.
26. Folkman, J. Angiogenesis and its inhibitors. Impo. Adv. Oncol. 1985, 42-62.
27. Williams, J. I. Squalamine: A new angiostatic steroid. Antiangiogenic Agents Cancer Ther. 1999, 153-174.
28. Teicher, B. A.; Williams, J. I.; Takeuchi, H.; Ara, G.; Herbst, R. S.; Buxton, D. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma. Anticancer Res. 1998, 18, 2567-2573.
29. Schiller, J. H.; Bittner, G. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization. Clin. Cancer Res. 1999, 5, 4287-4294.
30. Williams, J. I.; Weitman, S.; Gonzalez, C. M.; Jundt, C. H.; Marty, J.; Stringer, S. D.; Holroyd, K. J.; McLane, M. P.; Chen, Q.; Zasloff, M.; Von Hoff, D. D. Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies. Clin. Cancer Res. 2001, 7, 724-733.
31. Sills, A. K. Jr.; Williams, J. I.; Tyler, B. M.; Epstein, D. S.; Sipos, E. P.; Davis, J. D.; McLane, M. P.; Pitchford, S.; Cheshire, K.; Gannon, F. H.; Kinney, W. A.; Chao, T. L.; Donowitz, M.; Laterra, J.; Zasloff, M.; Brem, H. Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res. 1998, 58, 2784-2792.
32. Li, D.; Williams, J. I.; Pietras, R. J. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene 2002, 21, 2805-2814.
33. Bhargava, P.; Marshall, J. L.; Dahut, W.; Rizvi, N.; Trocky, N.; Williams, J. I.; Hait, H.; Song, S.; Holroyd, K. J.; Hawkins, M. J. A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers. Clin. Cancer Res. 2001, 7, 3912-3919.
34. Hao, D.; Hammond, L. A.; Eckhardt, S. G.; Patnaik, A.; Takimoto, C. H.; Schwartz, G. H.; Goetz, A. D.; Tolcher, A. W.; McCreery, H. A.; Mamun, K.; Williams, J. I.; Holroyd, K. J.; Rowinsky, E. K. A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor. Clin. Cancer Res. 2003, 9, 2465-2471.
35. Herbst, R. S.; Hammond, L. A.; Carbone, D. P.; Tran, H. T.; Holroyd, K. J.; Desai, A.; Williams, J. I.; Bekele, B. N.; Hait, H.; Allgood, V.; Solomon, S.; Schiller, J. H. A Phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. Clin. Cancer Res. 2003, 9, 4108-4115.
36. Shepherd, F. A.; Sridhar, S. S. Angiogenesis inhibitors under study for the treatment of lung cancer. Lung Cancer 2003, 41(Suppl.1), S63-S72.
37. Ozols, R. F. Paclitaxel plus carboplatin in the treatment of ovarian cancer. Sem. Oncol. 1999, 26, 84-89.
38. Pierce, E. A.; Avery, R. L.; Foley, E. D.; Aiello, L. P.; Smith, L. E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 1995, 92, 905-909.
39. Young, T. L.; Anthony, D. C.; Pierce, E.; Foley, E.; Smith, L. E. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. Journal of AAPOS: Official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus 1997, 1, 105-110.
40. Higgins, R. D.; Sanders, R. J.; Yan, Y.; Zasloff, M.; Williams, J. I. Squalamine improves retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 2000, 41, 1507-1512.
41. Genaidy, M.; Kazi Abdul, A.; Peyman Gholam, A.; Passos-Machado, E.; Farahat Hassan, G.; Williams Jon, I.; Holroyd Kenneth, J.; Blake Diane, A. Effect of squalamine on iris neovascularization in monkeys. Retina 2002, 22, 772-778.
42. Ciulla, T. A.; Criswell Mark, H.; Danis Ronald, P.; Williams Jon, I.; McLane Michael, P.; Holroyd Kenneth, J. Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat. Retina 2003, 23, 808-814.
43. Mokdad, A. H.; Bowman, B. A.; Ford, E. S.; Vinicor, F.; Marks, J. S.; Koplan, J. P. The continuing epidemics of obesity and diabetes in the United States. J. Am. Med. Assoc. 2001, 286, 1195-1200.
44. Zasloff, M.; Williams, J. I.; Chen, Q.; Anderson, M.; Maeder, T.; Holroyd, K.; Jones, S.; Kinney, W.; Cheshire, K.; McLane, M. A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties. Int. J. Obesity 2001, 25, 689-697.
45. Ahima, R. S.; Patel, H. R.; Takahashi, N.; Qi, Y.; Hileman, S. M.; Zasloff, M. A. Appetite suppression and weight reduction by a centrally active aminosterol. Diabetes 2002, 51, 2099-2104.